Skip to main content
HOKUYAKU TAKEYAMA Holdings,Inc. logo

HOKUYAKU TAKEYAMA Holdings,Inc. — Investor Relations & Filings

Ticker · 3055 ISIN · JP3843360003 T Wholesale and retail trade
Open in API
Filings indexed 67 across all filing types
Latest filing 2026-01-08 Transaction in Own Shar…
Country JP Japan
Listing T 3055

About HOKUYAKU TAKEYAMA Holdings,Inc.

https://www.hokutake.co.jp/

HOKUYAKU TAKEYAMA Holdings, Inc. is a holding company that operates through its subsidiaries in the wholesale of pharmaceuticals and medical equipment. The company distributes a wide range of products, including prescription drugs, over-the-counter medicines, and various medical devices. In addition to its core distribution business, the company provides comprehensive support services to medical institutions. These value-added services include medical management consulting, providing industry information, offering support for the establishment of new medical practices, and conducting professional training programs in areas such as communication and business etiquette.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on the Status of Share Repurchase' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activities for the period of December 2025. Since the document specifically reports on the company buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2026-01-08 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a report (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 20
2025-11-10 Japanese
半期報告書－第20期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MDA), and corporate information for the interim period ending September 30, 2025. It is a formal financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-10 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act because resolutions were made at the Annual General Meeting (AGM) held on June 27, 2025. Section 2 details the resolutions, specifically the election of 12 directors, and provides the vote counts (For, Against, Abstain) and the final result (Passed). This structure—a formal filing reporting the results of a shareholder vote at a general meeting—perfectly matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the core content is the voting outcome report, not the AGM presentation materials (AGM-R).
2025-07-02 Japanese
内部統制報告書－第19期(2024/04/01－2025/03/31)
Audit Report / Information Classification · 1% confidence The document explicitly states its title multiple times as "内部統制報告書" (Internal Control Report). The legal basis cited is Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項), which mandates the filing of an Internal Control Report in Japan. The content discusses the framework, scope, criteria, and conclusion regarding the assessment of internal controls over financial reporting as of March 31, 2025. This directly corresponds to the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although this specific document is focused purely on internal controls over financial reporting, which falls under the broader scope of assurance/audit-related documentation that is not the full Annual Report (10-K). Given the specific nature of the Japanese filing, 'AR' (Audit Report / Information) is the most appropriate classification among the provided options for a formal internal control assessment report. FY 2025
2025-06-26 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references Article 24-4-2 of the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2025
2025-06-26 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.